NamKoong C, Kim MS, Jang B-T, Lee YH, Cho Y-M, Choi HJ
Clinicians should be aware of this potential risk [for thyroid cancer] in initiating a GLP-1 receptor agonist and carefully monitor exposed patients, especially in the presence of other risk factors for thyroid cancer, the researchers wrote.
I was on it only for 7 months
The brokerage estimates Indias weight-loss market at about $500 million, which could rise to $1 billion with the right pricing, adoption and government incentives. Demand for these weight-loss drugs is also high as Indias 1.4-billion-plus population faces a higher burden of diabetes and cardiovascular ailments, largely due to increasingly sedentary urban lifestyles
Humulin R and Humulin N are approved for use in adults and children with type 1 or type 2 diabetes
B12 may counteract medication and diet-related fatigue Fatigue is a common symptom that many patients experience while taking tirzepatide for weight loss